ENVB
Enveric Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.41
+2.17%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-108.0%
Return on equity
-97.6%
Return on assets
-108.0%
Return on invested capital
0.00x
Asset turnover
-$8.6M
Cash from operations
$1.85
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026